By Ann Czarnik, M.D., Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health
If you’re looking into medical weight loss in Austin, you’ve probably seen two medication names everywhere: semaglutide and tirzepatide. You may know them better by the brand names used for diabetes and weight loss, but the real question most patients ask is simple: which one is right for me?
It’s a fair question, and one that deserves a medical answer rather than a marketing pitch.
I’ve spent more than 20 years in emergency medicine, including nearly a decade as Assistant Residency Director at UT Austin. I’ve seen firsthand what happens when metabolic disease is left unchecked: heart attacks, strokes, blood sugar crises, and joint damage that could often have been prevented earlier. What drew me to GLP-1 prescribing was the opportunity to intervene before those emergencies happen and help patients change the course of their health.
Here’s what I tell my patients in Austin when they ask about these medications.
They Work Differently, and That Matters
Both semaglutide and tirzepatide are GLP-1 receptor agonists. They mimic a hormone your body naturally produces that helps regulate blood sugar, slows digestion, and signals fullness to the brain.
The difference is that tirzepatide works through two pathways instead of one. In addition to activating the GLP-1 receptor, it also activates a second receptor called GIP. Semaglutide is a single-pathway approach to appetite and blood sugar regulation, while tirzepatide adds a second metabolic pathway that may further influence insulin sensitivity, fat metabolism, and satiety.
In clinical trials, that dual mechanism has translated into greater average weight loss for many tirzepatide patients. But individual results vary depending on starting weight, metabolic health, nutrition, activity level, and medication tolerance, which is exactly why this decision should be made with a physician who understands your full picture.
Semaglutide vs. Tirzepatide at a Glance
Semaglutide
- Mechanism: GLP-1 receptor agonist (single pathway)
- Weight loss results: Significant, well-documented
- Clinical history: Longer track record
- Best fit: Many patients respond well; strong option for patients who want a proven, established medication
Tirzepatide
- Mechanism: GLP-1 + GIP receptor agonist (dual pathway)
- Weight loss results: Often greater in clinical trials
- Clinical history: Newer dual-pathway therapy
- Best fit: May work better for some patients depending on goals and tolerance
It’s Not Just About Pounds Lost
As a physician, what matters to me goes well beyond the number on the scale. Both medications can improve blood sugar regulation, cardiovascular risk markers, insulin resistance, and systemic inflammation. Many patients also notice improvements in blood pressure, cholesterol, energy, and sleep quality.
This is why I believe GLP-1 medications should be prescribed by a physician who understands your broader health history, not by someone simply processing an online form. When I start a patient on either medication, I’m looking at their metabolic panel, cardiovascular risk, hormonal health, current medications, and long-term goals. The right medication for one patient may not be the right choice for another.
Austin has no shortage of clinics offering these medications, from med spas to plastic surgery offices to online pharmacies. Writing a prescription is the easy part. Managing the patient on these medications is where the real medicine happens.
Common Side Effects, and How We Handle Them
The most common side effects are gastrointestinal: nausea, reduced appetite, constipation, and occasional diarrhea. These are usually most noticeable in the first few weeks and during dose increases.
The key to minimizing side effects is careful dose titration. We start low, increase gradually, and adjust based on how the individual patient is responding. This is where having a physician who knows you makes a real difference. We adjust the timeline to your body, not a one-size-fits-all protocol.
If a patient has persistent difficulty with one medication, switching to the other is sometimes the better option. Semaglutide and tirzepatide affect people differently, and having a physician who can navigate those differences and stay accessible when questions come up matters.
Who Is a Good Candidate?
Both medications are FDA-approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or elevated cholesterol.
But candidacy is not just about BMI. I also consider:
- Your medical history, including certain thyroid conditions, pancreatitis history, and pregnancy
- Other medications you’re currently taking
- What you’ve tried before and what has or has not worked
- Your long-term goals, because a short-term jumpstart looks different from a sustained weight management program
These are conversations that take time. Not a three-minute checkout.
How We Do It at Amanecia Health in Austin
At our Austin practice, I work with each patient individually. Consultations happen through telemedicine or in-home visits. No waiting room, no rush. We take the time to understand what is happening metabolically before writing a prescription.
After the initial consultation and lab review, I recommend a starting medication and dose based on the patient’s specific profile. From there, we do regular follow-ups, not because it is a billing requirement, but because these medications need to be monitored. Dose adjustments, side effect management, nutritional guidance, and simply checking in on how the patient is feeling are all part of how we practice.
Amanecia is physician-led and relationship-based. The goal is not just access to medication, but thoughtful medical oversight and continuity.
We accept HSA and FSA payments, and for patients who choose manufacturer-direct fulfillment options like LillyDirect, we are available for consultations and reorders as well. Visit our patient resources page for more information.
Many of my patients come in for weight loss and end up staying with Amanecia for broader health needs such as urgent care, hormone therapy, and wellness. Once you have a physician who actually knows your story, the relationship tends to stick. Not because of a contract, but because it works.
The Bottom Line
Semaglutide and tirzepatide are both well-studied, effective medications that can produce meaningful weight loss and broader metabolic improvements when used under proper medical supervision. Tirzepatide tends to produce greater average results in studies because of its dual mechanism, but semaglutide has a longer track record and remains highly effective and well tolerated for many patients.
The right choice depends on your body, your health history, and your goals. And it should be made with a physician who takes the time to understand all three, not a med spa upselling you on the way to a cosmetic procedure.
If you’re in Austin and considering GLP-1 weight loss treatment, I’d welcome the conversation.
Related Reading
- What Is Concierge Medicine? A Guide for Austin Patients
- Why Your Weight Loss Doctor’s Background Matters
Ann Czarnik, M.D. is a board-certified Emergency Medicine physician with more than 20 years of clinical experience, including nearly a decade as Assistant Residency Director at The University of Texas at Austin. She co-founded Amanecia Health to deliver physician-led concierge medicine that puts the patient relationship first. She sees patients in Austin through telemedicine and in-home visits.